Whitepaper

New White Paper on Diversity, Equity, & Inclusion

Diversity, equity, and inclusion practices are sweeping the business world, particularly in diverse countries like the United States. Generational turnover in the US workforce is a key driver of adopting policies that are no longer seen as “feel-good” or just fair, but savvy mainstream business practices. As Gen Z takes its place in professional life …

New White Paper on Diversity, Equity, & Inclusion Read More »

New White Paper on Digital Opinion Leaders

It seems nothing (and no one) in our modern world has escaped the changes brought on by a migration to the digital space. In the pharmaceutical and life sciences category, the key opinion leader (KOL) is no exception. Digital opinion leaders (DOLs) have taken an ever-growing role in shaping treatment and disease management discussions. COVID-19 …

New White Paper on Digital Opinion Leaders Read More »

White Paper: Patient Engagement

Technological and cultural forces are shifting the expectations that patients bring to their healthcare. Armed with the ever-growing availability of information (and misinformation) on the internet, patients are asking more questions and taking a more active role in their care. As a result, pharmaceutical companies must optimize how they listen to and engage with patients …

White Paper: Patient Engagement Read More »

White Paper: Building Speakers Bureaus

The pharmaceutical industry has long used speakers bureaus and their associated meetings and events to educate healthcare providers (HCPs) about drug therapies and the diseases those drugs treat. However, while the value of a speakers bureaus is clear, the practice has been, at times, misused. Industry players must be deliberate with a keen eye on compliance when leveraging this powerful …

White Paper: Building Speakers Bureaus Read More »